GSE195663 7 V 1 CISPLATIN HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE195663 7 V 1 CISPLATIN HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE195663 7 V 1 CISPLATIN HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE195663 7 V 1 CISPLATIN HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE195663 7 V 1 CISPLATIN HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

ral guanine nucleotide dissociation stimulator like 2

Gene

H3 clustered histone 7

Gene

RNA polymerase II subunit J3

Gene

coiled-coil domain containing 200

Gene

C-C motif chemokine ligand 16

Gene

small integral membrane protein 41

Gene

transmembrane O-methyltransferase

Gene

tandem C2 domains, nuclear

Gene

olfactory receptor family 2 subfamily D member 3

  • Gene

    H4 clustered histone 15


  • Gene

    ral guanine nucleotide dissociation stimulator like 2


  • Gene

    H3 clustered histone 7


  • Gene

    RNA polymerase II subunit J3


  • Gene

    coiled-coil domain containing 200


  • Gene

    C-C motif chemokine ligand 16


  • Gene

    small integral membrane protein 41


  • Gene

    transmembrane O-methyltransferase


  • Gene

    tandem C2 domains, nuclear


  • Gene

    olfactory receptor family 2 subfamily D member 3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.